Cellular Senescence as a Mechanism and Target in Chronic Lung Diseases
- PMID: 30860857
- DOI: 10.1164/rccm.201810-1975TR
Cellular Senescence as a Mechanism and Target in Chronic Lung Diseases
Abstract
Cellular senescence is now considered an important driving mechanism for chronic lung diseases, particularly chronic obstructive pulmonary disease (COPD) and idiopathic pulmonary fibrosis. Cellular senescence is due to replicative and stress-related senescence with activation of p53 and p16INK4a, respectively, leading to activation of p21CIP1 and cell cycle arrest. Senescent cells secrete multiple inflammatory proteins known as the senescence-associated secretory phenotype, leading to low-grade chronic inflammation, which further drives senescence. Loss of key antiaging molecules sirtuin-1 and sirtuin-6 may be important in acceleration of aging and arises from oxidative stress reducing phosphatase PTEN (phosphatase tensin homolog), thereby activating PI3K (phosphoinositide-3-kinase) and mTOR (mammalian target of rapamycin). MicroRNA-34a (miR-34a), which is regulated by PI3K-mTOR signaling, plays a pivotal role in reducing sirtuin-1/6, and its inhibition with an antagomir results in their restoration, reducing markers of senescence, reducing senescence-associated secretory phenotype, and reversing cell cycle arrest in epithelial cells from peripheral airways of patients with COPD. miR-570 is also involved in reduction of sirtuin-1 and cellular senescence and is activated by p38 mitogen-activated protein kinase. These miRNAs may be released from cells in extracellular vesicles that are taken up by other cells, thereby spreading senescence locally within the lung but also outside the lung through the circulation; this may account for comorbidities of COPD and other lung diseases. Understanding the mechanisms of cellular senescence may result in new treatments for chronic lung disease, either by inhibiting PI3K-mTOR signaling, by inhibiting specific miRNAs, or by deletion of senescent cells with senolytic therapies, already shown to be effective in experimental lung fibrosis.
Keywords: microRNA; senescence-associated secretory phenotype; senolytic; sirtuin; telomere.
Similar articles
-
Senotherapy: A New Horizon for COPD Therapy.Chest. 2020 Aug;158(2):562-570. doi: 10.1016/j.chest.2020.01.027. Epub 2020 Feb 10. Chest. 2020. PMID: 32057805 Review.
-
MicroRNA-570 is a novel regulator of cellular senescence and inflammaging.FASEB J. 2019 Feb;33(2):1605-1616. doi: 10.1096/fj.201800965R. Epub 2018 Aug 29. FASEB J. 2019. PMID: 30156909 Free PMC article.
-
Oxidative stress dependent microRNA-34a activation via PI3Kα reduces the expression of sirtuin-1 and sirtuin-6 in epithelial cells.Sci Rep. 2016 Oct 21;6:35871. doi: 10.1038/srep35871. Sci Rep. 2016. PMID: 27767101 Free PMC article.
-
Senotherapy for lung diseases.Adv Pharmacol. 2023;98:249-271. doi: 10.1016/bs.apha.2023.04.001. Epub 2023 Apr 20. Adv Pharmacol. 2023. PMID: 37524489
-
Senolytic drugs in respiratory medicine: is it an appropriate therapeutic approach?Expert Opin Investig Drugs. 2018 Jul;27(7):573-581. doi: 10.1080/13543784.2018.1492548. Epub 2018 Jul 4. Expert Opin Investig Drugs. 2018. PMID: 29972333 Review.
Cited by
-
miR-21-Mediated Endothelial Senescence and Dysfunction Are Involved in Cigarette Smoke-Induced Pulmonary Hypertension through Activation of PI3K/AKT/mTOR Signaling.Toxics. 2024 May 29;12(6):396. doi: 10.3390/toxics12060396. Toxics. 2024. PMID: 38922076 Free PMC article.
-
Noncoding RNAs in chronic obstructive pulmonary disease: From pathogenesis to therapeutic targets.Noncoding RNA Res. 2024 Jun 4;9(4):1111-1119. doi: 10.1016/j.ncrna.2024.06.005. eCollection 2024 Dec. Noncoding RNA Res. 2024. PMID: 39022682 Free PMC article. Review.
-
Senescence: Pathogenic Driver in Chronic Obstructive Pulmonary Disease.Medicina (Kaunas). 2022 Jun 17;58(6):817. doi: 10.3390/medicina58060817. Medicina (Kaunas). 2022. PMID: 35744080 Free PMC article. Review.
-
Targeting accelerated pulmonary ageing to treat chronic obstructive pulmonary disease-induced neuropathological comorbidities.Br J Pharmacol. 2024 Jan;181(1):3-20. doi: 10.1111/bph.16263. Epub 2023 Nov 15. Br J Pharmacol. 2024. PMID: 37828646 Free PMC article. Review.
-
Mechanisms and Regulation of Cellular Senescence.Int J Mol Sci. 2021 Dec 6;22(23):13173. doi: 10.3390/ijms222313173. Int J Mol Sci. 2021. PMID: 34884978 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous